Cargando…
Novel Biomarkers of Alzheimer’s Disease: Based Upon N-methyl- D-aspartate Receptor Hypoactivation and Oxidative Stress
Early detection and prevention of Alzheimer’s disease (AD) is important. The current treatment for early AD is acetylcholine esterase inhibitors (AChEIs); however, the efficacy is poor. Besides, AChEI did not show efficacy in mild cognitive impairment (MCI). Beta-amyloid (Aβ) deposits have been rega...
Autores principales: | Chiang, Ting-I, Yu, Yi-Hsiang, Lin, Chieh-Hsin, Lane, Hsien-Yuan |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Korean College of Neuropsychopharmacology
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8316669/ https://www.ncbi.nlm.nih.gov/pubmed/34294612 http://dx.doi.org/10.9758/cpn.2021.19.3.423 |
Ejemplares similares
-
The Role of N-Methyl-D-Aspartate Receptor Neurotransmission and Precision Medicine in Behavioral and Psychological Symptoms of Dementia
por: Lin, Chieh-Hsin, et al.
Publicado: (2019) -
An Ensemble Approach to Predict Schizophrenia Using Protein Data in the N-methyl-D-Aspartate Receptor (NMDAR) and Tryptophan Catabolic Pathways
por: Lin, Eugene, et al.
Publicado: (2020) -
Current Status of Biomarkers in Anti-N-Methyl-D-Aspartate Receptor Encephalitis
por: Ciano-Petersen, Nicolás Lundahl, et al.
Publicado: (2021) -
Protein quality control of N-methyl-D-aspartate receptors
por: Benske, Taylor M., et al.
Publicado: (2022) -
Specific motor cortex hypoexcitability and hypoactivation in COPD patients with peripheral muscle weakness
por: Alexandre, Francois, et al.
Publicado: (2020)